Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 59Other hematologic neoplasm 17Plasma cell 4Sarcoma 3Dermatologic 2Thoracic 1Myeloid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Small Cell Lung Carcinoma 4Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lung Neoplasms 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Gemcitabine 4tazemetostat 2pembrolizumab 2Rituximab 2Itraconazole 2Cyclophosphamide 2Cisplatin 2vandetanib 1utomilumab 1temsirolimus 1sargramostim 1ruxolitinib 1motexafin gadolinium 1motesanib diphosphate 1fludarabine 1enzalutamide 1entinostat 1carboxyamido-triazole 1avelumab 1Watchful Waiting 1Vorinostat 1Topotecan 1Thalidomide 1Ritonavir 1Rifampin 1Radiotherapy 1Polymerase Chain Reaction 1Pemetrexed 1Paclitaxel 1PF06821497 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Bendamustine Hydrochloride × Thoracic × Clear all
NCT03997968 2024-12-24

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Cyteir Therapeutics, Inc.

Phase 1/2 Completed
169 enrolled
BreastGastrointestinalGynecologicHead & NeckLymphoidPlasma cellSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Head and Neck Neoplasms, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Lymphoma, Mantle-Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡